90 likes | 242 Views
Pr André Syrota. 3 rd International Biomedical Research Meeting June 10 th 2011 Résidence de Marigny. The French Alliance for Life and Health Sciences: Aviesan. Created in April 2009 To optimise scientific foresight and put forward scientific programming to Funding Agencies
E N D
Pr André Syrota 3rd International Biomedical Research Meeting June 10th 2011 Résidence de Marigny
The French Alliance for Life and Health Sciences: Aviesan Created in April 2009 To optimise scientific foresight and put forward scientific programming to Funding Agencies To facilitate the development of top-level clusters and research centers To promote national projects and to set up national core facilities • Research operating agencies : • Inserm • CNRS life sciences department • CEA (atomic energy commission) • Inra (national institute for agricultural research) • Inria (computer science and automatic control) • IRD (research for development) • Pasteur Institute • Universities • Hospitals 2
Ten Thematic Institutes covering the entire field of Life and health Sciences Immunology Hematology Respiratory diseases Genetics, Genomics Bioinformatics Neurosciences Cognitive Sciences Neurology, Psychiatry Cell Biology Development Microbiology Infectious diseases Keywords: Sharing a common strategy to ensure an improved coordination Molecular and Structural Biology Nutrition Circulation Metabolism Public Health Health Technologies Cancer 3
« Epidemiologie France » : a new internet portal for health research • A web catalog of major health databases from French sources that may be useful to improve research and public health expertise • This catalog contains descriptions of 237 databases including 130 cohort studies, 76 industrial studies and 31 morbidity registries • A standardized description form for each database describes the main features: aims, population, methods, acces modes, responsible of the database • Search engineand browse tools allows the visitor to explore the on line catalog in three ways: browse, simple and advanced search • English version under construction http://epidemiologie-france.fr
Investments for the future : a major opportunity for boosting R&I 35 billion € 21.9 devoted to Research and Higher education
10 cohorts • CANTO (breast cancer) : Institut Gustave Roussy / Inserm • OFSEP (multiple sclerosis) : Université Claude Bernard Lyon 1 / Hospices civils de Lyon / Inserm • RADICO (rare diseases) : Inserm • i-SHARE (relationship between behaviour or exposure and pathogenesis among young adults) : Université de Bordeaux / Inserm / Université de Versailles Saint Quentin • E4N (genetics and biological risk factors) : Institut Gustave Roussy / Inserm • HOPE-EPI (pediatric cancers) : Inserm • CKD-REIN (chronic renal insufficiency) : Université Paris Sud 11 • CRYOSTEM (transplant rejection and leukemia) : Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) • COBLAnce (bladder cancer) : Inserm • Psy-COH (chronic psychiatric disorders) : Fondation FondaMental 70 millions € for 10 years
9 national research infrastructures for biology and health • BIOBANQUES (public health, biomarkers), coordination Inserm • F- CRIN (clinical research), coordination Inserm • HIDDEN (biosafety level 4 laboratory), Inserm • France-BioImaging (cell imaging), coordination CNRS • FRISBI (structural biology), coordination CNRS • PHENOMIN (phenotyping), coordination CNRS • ProFI (proteomics), coordination CNRS • France Génomique (genomics), coordination CEA • EMBRC-France (marine biology), université Pierre et Marie Curie, CNRS 220 millions € for 10 years
6 university hospitals « Instituts hospitalo-universitaires » • Neurosciences (Paris) • Cardiometabolism and nutrition (Paris) • Genetic diseases (Paris) • Cardiology (Bordeaux) • Surgery (Strasbourg) • Infectious diseases (Marseille) 350 millions € for 10 years